CN106420871B - Preparation method of total notoginsenoside rich in Fe and Fd and monomers Fe and Fd thereof - Google Patents
Preparation method of total notoginsenoside rich in Fe and Fd and monomers Fe and Fd thereof Download PDFInfo
- Publication number
- CN106420871B CN106420871B CN201610862430.3A CN201610862430A CN106420871B CN 106420871 B CN106420871 B CN 106420871B CN 201610862430 A CN201610862430 A CN 201610862430A CN 106420871 B CN106420871 B CN 106420871B
- Authority
- CN
- China
- Prior art keywords
- panax notoginseng
- preparation
- extract
- extraction
- saponins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J17/005—Glycosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明属于天然药物制备技术领域,具体涉及一种富含Fe、Fd的三七总皂苷及其单体Fe和Fd的制备方法。The invention belongs to the technical field of natural medicine preparation, in particular to a preparation method of Fe, Fd-rich Panax notoginseng saponins and its monomers Fe and Fd.
背景技术Background technique
三七为五加科植物三七[Panax notoginseng(Burk.)F.H.Chen]的干燥根,为我国名贵中药,其主要有效成分为皂苷类化合物,三七多以根或根茎入药。研究发现三七叶具有安神、降压、镇痛、消炎等功效,然而其利用率仅有5%,大部分可利用资源被丢弃。三七叶和三七花中含有大量达玛烷型原人参二醇型人参皂苷,以人参皂苷Rb3、Rb2和Rc为主要成分,而三七皂苷Fe和Fd的含量极低,因此其药理作用报道也很少。为了进一步开发三七叶/花及稀有人参皂苷,如何获得富含三七皂苷Fe和Fd的三七总皂苷、以及大量快速制备三七皂苷Fe和Fd化学单体是目前亟待解决的问题。Panax notoginseng (Panax notoginseng (Burk.) FHChen) is the dry root of Panax notoginseng (Burk.) FHChen. Studies have found that Panax notoginseng leaves have the effects of calming the nerves, lowering blood pressure, analgesia, and anti-inflammatory. However, its utilization rate is only 5%, and most of the available resources are discarded. The leaves and flowers of Panax notoginseng contain a large amount of dammarane-type protopanaxadiol-type ginsenosides, with ginsenosides Rb 3 , Rb 2 and Rc as the main components, while the content of notoginsenosides Fe and Fd is extremely low, so its There are few reports of pharmacological effects. In order to further develop Panax notoginseng leaves/flowers and rare ginsenosides, how to obtain Panax notoginseng saponins rich in Fe and Fd of Panax notoginseng saponins, and how to quickly prepare a large number of chemical monomers of Panax notoginseng saponins Fe and Fd is an urgent problem to be solved.
发明内容SUMMARY OF THE INVENTION
有鉴于此,本发明的目的是提供一种富含Fe、Fd的三七总皂苷及其单体Fe和Fd的制备方法。本发明的制备方法能够大大提高稀有三七皂苷Fe和Fd在总皂苷中的含量,同时通过简单的分离纯化方法即可获得高含量的三七皂苷Fe和Fd单体。In view of this, the object of the present invention is to provide a preparation method of Fe, Fd-rich Panax notoginseng saponins and monomers Fe and Fd. The preparation method of the invention can greatly increase the content of rare Panax notoginseng saponins Fe and Fd in the total saponins, and simultaneously can obtain high content of Panax notoginseng saponins Fe and Fd monomers through a simple separation and purification method.
为了实现上述目的,本发明提供一种富含Fe、Fd的三七总皂苷及其单体Fe和Fd的制备方法,包括如下步骤:In order to achieve the above object, the present invention provides a kind of preparation method of Fe, Fd-rich Panax notoginseng saponins and its monomers Fe and Fd, comprising the steps:
(1)将三七药材加入温水中浸泡10~200min,然后加入乙醇水溶液或水进行提取,得到提取液,其中,所述三七药材包括三七叶和/或三七花;(1) soaking the medicinal materials of Panax notoginseng in warm water for 10-200 min, and then adding an aqueous ethanol solution or water for extraction to obtain an extract, wherein the medicinal materials of Panax notoginseng include Panax notoginseng leaves and/or Panax notoginseng flowers;
(2)将提取液上大孔吸附树脂柱,用乙醇水溶液洗脱,即得富含稀有三七皂苷Fe和Fd的三七总皂苷。(2) Putting the extract on a macroporous adsorption resin column and eluting it with an aqueous ethanol solution to obtain total notoginseng saponins rich in rare notoginseng saponins Fe and Fd.
其中,步骤(1)中,所述三七药材优选粉末状三七药材,即三七药材粉末,更优选规格为20~60目的三七药材粉末。Wherein, in step (1), the Panax notoginseng medicinal material is preferably a powdered Panax notoginseng medicinal material, that is, a Panax notoginseng medicinal material powder, and more preferably a Panax notoginseng medicinal material powder with a specification of 20-60 meshes.
所述温水的温度优选10~80℃,更优选40~70℃。The temperature of the warm water is preferably 10 to 80°C, more preferably 40 to 70°C.
所述浸泡的时间优选30~90min。The soaking time is preferably 30-90 min.
浸泡时,所述三七药材与温水的质量体积比优选为1:1~1:10,此处,所述的质量体积比是本领域常规的含义,其单位可以是kg/L或g/mL,举例来说,1kg三七药材浸泡于1L温水的质量体积比即为1:1。When soaking, the mass-volume ratio of the notoginseng medicinal materials and warm water is preferably 1:1 to 1:10. Here, the mass-volume ratio is the conventional meaning in the art, and its unit can be kg/L or g/L. For example, the mass-to-volume ratio of 1kg of Panax notoginseng medicinal materials soaked in 1L of warm water is 1:1.
步骤(1)中,所述乙醇水溶液的浓度为本领域常规所述,其浓度可以是0~100%(v/v)任意,优选70~90%,所述三七药材与所述乙醇水溶液的质量体积比优选为1:1~1:100,更优选1:20~1:25,此处,所述的质量体积比是本领域常规的含义,其单位可以是kg/L或g/mL,举例来说,1kg三七药材用1L乙醇水溶液提取的质量体积比即为1:1。In step (1), the concentration of the aqueous ethanol solution is conventional in the art, and its concentration can be any value from 0 to 100% (v/v), preferably 70 to 90%. The mass-volume ratio is preferably 1:1~1:100, more preferably 1:20~1:25, here, the mass-volume ratio is the conventional meaning in the art, and its unit can be kg/L or g/ mL, for example, the mass-volume ratio of 1kg of Panax notoginseng medicinal materials extracted with 1L of ethanol aqueous solution is 1:1.
步骤(1)中,所述提取为本领域常规的操作,优选渗漉提取、热回流提取和超声提取中的任一种;所述提取的时间优选1~6h,更优选90~150min。In step (1), the extraction is a conventional operation in the field, preferably any one of percolation extraction, thermal reflux extraction and ultrasonic extraction; the extraction time is preferably 1-6 hours, more preferably 90-150 minutes.
步骤(2)中,在将提取液上大孔吸附树脂柱之前,还优选对所述提取液进行减压浓缩,之后将浓缩后的提取液上大孔吸附树脂柱;若在步骤(1)中加入了乙醇水溶液进行提取,则优选对所述提取液进行减压浓缩至无醇味后,之后将浓缩后的提取液上大孔吸附树脂柱。In step (2), before applying the extract to the macroporous adsorption resin column, it is also preferable to concentrate the extract under reduced pressure, and then apply the concentrated extract to the macroporous adsorption resin column; if in step (1) If an ethanol aqueous solution is added to the extract, the extract is preferably concentrated under reduced pressure until there is no alcohol smell, and then the concentrated extract is placed on a macroporous adsorption resin column.
步骤(2)中,所述大孔吸附树脂优选X-5、AB-8、DM-301、NK-2、NKA-2、NK-9、D-101和WLD中的任一种。In step (2), the macroporous adsorption resin is preferably any one of X-5, AB-8, DM-301, NK-2, NKA-2, NK-9, D-101 and WLD.
步骤(2)中,所述用乙醇水溶液洗脱可为本领域常规,优选地,是先以0~20%(v/v)乙醇水溶液洗涤,弃去洗液,再以40~100%(v/v)乙醇水溶液洗脱,收集洗脱液。In step (2), the eluting with ethanol aqueous solution can be conventional in the art, preferably, firstly, washing with 0-20% (v/v) ethanol aqueous solution, discarding the washing solution, and then washing with 40-100% (v/v) ethanol solution. v/v) Elution with an aqueous ethanol solution, and the eluate was collected.
步骤(2)中,优选地,在用乙醇水溶液洗脱之前,先用水洗至流出液为无色。In step (2), preferably, before washing with ethanol aqueous solution, wash with water until the effluent is colorless.
优选地,为了制得高含量的稀有三七皂苷Fe和Fd单体,所述富含Fe、Fd的三七总皂苷及其单体Fe和Fd的制备方法还包括如下步骤:Preferably, in order to obtain high-content rare Panax notoginseng saponins Fe and Fd monomers, the preparation method of the Fe, Fd-rich Panax notoginseng saponins and monomers Fe and Fd thereof also comprises the following steps:
(3)将步骤(2)所得的富含稀有三七皂苷Fe和Fd的三七总皂苷吸附于硅胶柱上,分别用氯仿-甲醇和乙酸乙酯-甲醇进行洗脱,分段收集合并三七皂苷Fe和Fd的流份,减压回收溶剂至干,即得到三七皂苷Fe和Fd的单体。(3) adsorbing the total notoginseng saponins rich in rare notoginseng saponins Fe and Fd obtained in step (2) on a silica gel column, eluting with chloroform-methanol and ethyl acetate-methanol respectively, collecting and combining three The fractions of heptasaponins Fe and Fd are recovered under reduced pressure to dry the solvent to obtain the monomers of notoginsenosides Fe and Fd.
其中,所述氯仿-甲醇中,优选氯仿与甲醇的体积比为20:1~1:1;所述乙酸乙酯-甲醇中,优选乙酸乙酯与甲醇的体积比为10:1~1:1。Wherein, in the chloroform-methanol, the volume ratio of chloroform to methanol is preferably 20:1 to 1:1; in the ethyl acetate-methanol, the volume ratio of ethyl acetate to methanol is preferably 10:1 to 1:1: 1.
本发明中,上述优选条件在符合本领域常识的基础上可任意组合,即得本发明各较佳实例。In the present invention, the above-mentioned preferred conditions can be arbitrarily combined on the basis of common knowledge in the art, to obtain each preferred embodiment of the present invention.
本发明所用的原料或试剂除特别说明之外,均市售可得。The raw materials or reagents used in the present invention are commercially available unless otherwise specified.
本发明取得了下述有益效果:The present invention has achieved the following beneficial effects:
采用本发明的制备方法获得的产品中总皂苷收率高,总皂苷含量可达84%(香草醛-高氯酸UV法),主要含三七皂苷Fe和Fd等成分,且三七皂苷Fe和Fd的富集程度和含量较高,其中三七皂苷Fe含量可达5.1%(HPLC法),三七皂苷Fd含量可达8.8%(HPLC法),所分离得到的三七皂苷Fe和Fd单体纯度均在90%以上,由此可见本发明的工艺效率高、耗时少、低成本、高效率,利于产业化高质量生产。The product obtained by the preparation method of the present invention has a high yield of total saponins, the content of total saponins can reach 84% (vanillin-perchloric acid UV method), mainly contains components such as notoginsenoside Fe and Fd, and notoginsenoside Fe The enrichment degree and content of Panax notoginseng saponins and Fd are relatively high, in which the Fe content of Panax notoginseng saponins can reach 5.1% (HPLC method), and the content of Panax notoginseng saponins Fd can reach 8.8% (HPLC method). The purity of the monomers is all above 90%, so it can be seen that the process of the present invention has high process efficiency, less time-consuming, low cost and high efficiency, and is conducive to industrialized high-quality production.
附图说明Description of drawings
图1是三七叶甲醇提取物(A)和水煎煮液(B)HPLC色谱图,其中1-3是人参皂苷Rc、Rb2和Rb3,4-5为三七皂苷Fe和Fd;Fig. 1 is the HPLC chromatogram of the methanol extract of Panax notoginseng leaves (A) and water decoction (B), wherein 1-3 are ginsenosides Rc, Rb 2 and Rb 3 , and 4-5 are notoginsenosides Fe and Fd;
图2A和图2B是水浸泡温度对转化效率的影响结果图;Fig. 2A and Fig. 2B are the result graphs of the effect of water immersion temperature on conversion efficiency;
图3A和图3B是水浸泡时间对转化效率的影响结果图;Figure 3A and Figure 3B are graphs of the effect of water immersion time on conversion efficiency;
图4是本发明实施例1中未经大孔吸附树脂处理的浓缩液(A),及所制备得到富含稀有三七皂苷Fe和Fd的三七叶总皂苷组合物产品(B)的HPLC图,其中1-3为人参皂苷Rc、Rb2和Rb3,4-5为三七皂苷Fe和Fd;Fig. 4 is the concentrated solution (A) without macroporous adsorption resin treatment in the embodiment of the
图5是本发明实施例1中分离得到的三七皂苷Fe(A)和三七皂苷Fd(B)单体HPLC色谱图。Fig. 5 is the HPLC chromatogram of the monomers of notoginsenoside Fe(A) and notoginsenoside Fd(B) separated in Example 1 of the present invention.
具体实施方式Detailed ways
为使本发明的目的、技术方案和优点更加清楚明白,以下结合具体实施例,并参照附图,对本发明作进一步的详细说明。In order to make the objectives, technical solutions and advantages of the present invention more clearly understood, the present invention will be further described in detail below in conjunction with specific embodiments and with reference to the accompanying drawings.
鉴于三七叶和三七花中含有大量达玛烷型原人参二醇型人参皂苷,以人参皂苷Rc、Rb2和Rb3为主要成分,而三七皂苷Fe和Fd的含量极低,因此其药理作用报道也很少。为了加强对于稀有三七皂苷Fe和Fd的研究,实有必要首先提高稀有三七皂苷Fe和Fd的含量并对其进行分离和富集。申请人在大量的实验探究过程中,惊喜地发现,若在对三七药材进行醇提(或不以醇进行提取)之前,先用温水对三七药材进行一定时间的浸泡,则有助于三七皂苷Fe和Fd的生成转化,提高稀有三七皂苷Fe和Fd的含量。进一步地,若将三七药材粉碎至一定目数的粉末,并优化温水的温度和浸泡时间,则Fe和Fd生成转化的效率能够进一步提高。申请人经过大量的探索实验并经反复的实验验证,终于得到本发明的实验条件,结果表明,在本发明的实验参数范围下,均能够取得理想的效果。In view of the fact that the leaves and flowers of Panax notoginseng contain a large amount of dammarane-type protopanaxadiol-type ginsenosides, with ginsenosides Rc, Rb 2 and Rb 3 as the main components, while the content of Panax notoginseng saponins Fe and Fd is extremely low, so There are few reports on its pharmacological effects. In order to strengthen the research on rare Panax notoginseng saponins Fe and Fd, it is necessary to first increase the content of rare Panax notoginseng saponins Fe and Fd, and separate and enrich them. In the course of a large number of experiments and explorations, the applicant was pleasantly surprised to find that if the medicinal materials of Panax notoginseng were soaked in warm water for a certain period of time before alcohol extraction (or without alcohol extraction), it would help. The formation and transformation of Fe and Fd of Panax notoginseng saponins increase the content of Fe and Fd of rare Panax notoginseng saponins. Further, if the medicinal materials of Panax notoginseng are pulverized to a certain mesh size, and the temperature and soaking time of warm water are optimized, the conversion efficiency of Fe and Fd can be further improved. The applicant has finally obtained the experimental conditions of the present invention through a large number of exploration experiments and repeated experimental verifications. The results show that ideal effects can be achieved within the scope of the experimental parameters of the present invention.
申请人在前期研究中发现,三七叶甲醇或乙醇提取物中,三七皂苷Fe和Fd的含量极低,水煎煮液中三七皂苷Fe和Fd的含量有所提高,而人参皂苷Rc和Rb3含量相应地减少,结果如图1所示。进一步的研究发现,在纯水的情况下,人参皂苷Rc和Rb3在某种酶的作用下能够水解转化为三七皂苷Fe和Fd。申请人经过更进一步的研究发现,这种转化的效率跟温度有较大的相关性,经反复的实验验证发现50℃时的转化效率最高,而随着温度继续升高,则转化率开始慢慢下降,结果请见图2A和图2B。同时,申请人还对浸泡时间进行了考察,优化了浸泡时间,结果如图3A和图3B所示。The applicant found in the previous research that in the methanol or ethanol extract of Panax notoginseng leaves, the content of notoginsenoside Fe and Fd was extremely low, the content of notoginsenoside Fe and Fd in the water decoction was increased, and the ginsenoside Rc and Rb 3 content decreased accordingly, and the results are shown in Figure 1. Further research found that in the presence of pure water, ginsenosides Rc and Rb 3 can be hydrolyzed into notoginsenosides Fe and Fd under the action of a certain enzyme. After further research, the applicant found that the efficiency of this conversion has a greater correlation with the temperature. After repeated experimental verification, it was found that the conversion efficiency at 50°C was the highest, and as the temperature continued to increase, the conversion rate began to slow. Slow down, see Figure 2A and Figure 2B for results. At the same time, the applicant also investigated the soaking time and optimized the soaking time. The results are shown in Figure 3A and Figure 3B.
实施例1Example 1
将20g三七叶粉碎成40目粉末,加80mL的水在50℃下浸润0.5小时,然后加入400mL的70%乙醇回流提取60分钟,收集提取液,过滤,滤渣回收,继续加入400mL的70%乙醇回流提取60分钟,合并提取液,减压浓缩至相对密度为1.11;将浓缩液上D-101型大孔吸附树脂柱,其中大孔吸附树脂与浓缩液的体积比为2:1,柱径与柱高比为1:15,先用水洗至流出液为无色,再用15倍柱体积的20%乙醇冲洗,弃去冲洗液,最后用体积分数为60%的乙醇全部洗脱,收集洗脱液,回收溶剂至干即得富含稀有三七皂苷Fe和Fd的三七叶总皂苷组合物2.5g,经香草醛-高氯酸UV法检查,总皂苷纯度为84%。经HPLC法检查,其中三七皂苷Fe含量5.1%,三七皂苷Fd含量为8.8%。本实施例中,未经大孔吸附树脂处理的浓缩液(A),及经过大孔吸附树脂处理制得的富含稀有三七皂苷Fe和Fd的三七叶总皂苷组合物产品(B)的HPLC色谱图如图4所示,其中1-3为人参皂苷Rc,Rb2和Rb3,4-5为三七皂苷Fe和Fd。Pulverize 20g of Panax notoginseng leaves into 40 mesh powder, add 80mL of water to soak at 50°C for 0.5 hours, then add 400mL of 70% ethanol for reflux extraction for 60 minutes, collect the extract, filter, and recycle the filter residue, and continue to add 400mL of 70% ethanol. Reflux extraction with ethanol for 60 minutes, combine the extracts, and concentrate under reduced pressure to a relative density of 1.11; put the concentrate on a D-101 type macroporous adsorption resin column, wherein the volume ratio of macroporous adsorption resin to concentrate is 2:1, and the column The ratio of diameter to column height is 1:15, first wash with water until the effluent is colorless, then wash with 15 times the column volume of 20% ethanol, discard the washing liquid, and finally use 60% ethanol to elute all, The eluate was collected, and the solvent was recovered to dryness to obtain 2.5 g of the total saponin composition of Panax notoginseng leaves rich in rare Panax notoginseng saponins Fe and Fd. After the vanillin-perchloric acid UV method, the total saponin purity was 84%. The HPLC method showed that the Fe content of Panax notoginseng saponins was 5.1%, and the content of Panax notoginseng saponins Fd was 8.8%. In the present embodiment, the concentrated solution (A) without macroporous adsorption resin treatment, and the total saponin composition product (B) of Panax notoginseng leaves rich in rare Panax notoginseng saponins Fe and Fd obtained by macroporous adsorption resin treatment The HPLC chromatogram is shown in Figure 4, wherein 1-3 are ginsenosides Rc, Rb 2 and Rb 3 , and 4-5 are notoginsenosides Fe and Fd.
将制得的总皂苷吸附于2倍量的硅胶上,挥发至干,备用;装柱,将总皂苷10倍量的柱层析硅胶,用氯仿湿法装柱,反复用洗脱剂洗脱,使硅胶充分下沉紧密;上样及洗脱,将样品慢慢加入层析柱中,用氯仿-甲醇(体积比5:1)等度洗脱,分段收集,每流份收集量为4倍柱体积,经薄层色谱检测后合并含有三七皂苷Fe和Fd的流份,减压回收溶剂至干,再用硅胶柱层析法,用乙酸乙酯-甲醇(体积比5:1)等度洗脱,分段收集,每流份收集量为3倍柱体积,经薄层色谱检测后分别合并三七皂苷Fe和Fd流份,减压回收溶剂至干,得到三七皂苷Fe54.6mg和Fd 56.7mg。HPLC检测纯度各为90.6%和90.8%,分离得到的三七皂苷Fe(A)和三七皂苷Fd(B)单体的HPLC色谱图如图5所示。The prepared total saponins were adsorbed on 2 times the amount of silica gel, volatilized to dryness, and used for later use; loaded into a column, 10 times the amount of total saponins was used for column chromatography on silica gel, packed with chloroform wet method, and eluted with eluent repeatedly. , to make the silica gel fully sink and close; for sample loading and elution, slowly add the sample to the chromatography column, use chloroform-methanol (volume ratio 5:1) for isocratic elution, and collect in sections. 4 times the column volume, the fractions containing Notoginsenoside Fe and Fd were combined after detection by thin layer chromatography, the solvent was recovered under reduced pressure to dryness, and then silica gel column chromatography was used, and ethyl acetate-methanol (volume ratio 5:1) was used. ) isocratic elution, segmented collection, and the collection amount of each fraction is 3 times of column volumes, after TLC detection, merge notoginsenoside Fe and Fd fractions respectively, and the solvent is recovered under reduced pressure to dryness to obtain notoginsenoside Fe54 .6mg and Fd 56.7mg. The purity detected by HPLC was 90.6% and 90.8% respectively, and the HPLC chromatograms of the separated notoginsenoside Fe(A) and notoginsenoside Fd(B) monomers were shown in FIG. 5 .
实施例2Example 2
将10g三七花粉碎成50目粉末,加100mL水在40℃下浸润1.5小时,然后加入150mL90%乙醇超声提取60分钟,收集提取液,过滤,减压浓缩至相对密度为1.15;将浓缩液上X-5型大孔吸附树脂柱,其中大孔吸附树脂与浓缩液的体积比为1.5:1,柱径与柱高比为1:10,先用水洗至流出液为无色,再用10倍柱体积的20%乙醇冲洗,弃去冲洗液,最后用体积分数为70%的乙醇全部洗脱,收集洗脱液,回收溶剂至干即得富含稀有三七皂苷Fe和Fd的三七花总皂苷2.02g,经香草醛-高氯酸UV法检查,总皂苷纯度为64.7%。经HPLC法检查,其中三七皂苷Fe含量为4.23%,三七皂苷Fd含量为7.16%。Pulverize 10 g of Panax notoginseng flowers into 50 mesh powder, add 100 mL of water to soak at 40°C for 1.5 hours, then add 150 mL of 90% ethanol for ultrasonic extraction for 60 minutes, collect the extract, filter, and concentrate under reduced pressure to a relative density of 1.15; On the X-5 type macroporous adsorption resin column, the volume ratio of macroporous adsorption resin and concentrated solution is 1.5:1, and the ratio of column diameter to column height is 1:10. First wash with water until the effluent is colorless, and then use Rinse with 10 times the column volume of 20% ethanol, discard the rinse solution, and finally elute with 70% ethanol by volume. Seven flower total saponins 2.02g, the total saponin purity was 64.7% by vanillin-perchloric acid UV method. The HPLC method showed that the Fe content of Panax notoginseng saponins was 4.23%, and the content of Panax notoginseng saponins Fd was 7.16%.
将制得的总皂苷吸附于3倍量的硅胶上,挥发至干,备用;装柱,将总皂苷5倍量的柱层析硅胶,用氯仿湿法装柱,反复用洗脱剂洗脱,使硅胶充分下沉紧密;上样及洗脱,将样品慢慢加入层析柱中,用氯仿-甲醇(体积比20:1)等度洗脱,分段收集,每流份收集量为4倍柱体积,经薄层色谱检测后合并含有三七皂苷Fe和Fd的流份,减压回收溶剂至干,再用硅胶柱层析法,用乙酸乙酯-甲醇(体积比3:1)等度洗脱,分段收集,每流份收集量为3倍柱体积,经薄层色谱检测后分别合并三七皂苷Fe和Fd流份,减压回收溶剂至干得三七皂苷Fe21.0mg和Fd 23.4mg。HPLC检测纯度各为82.1%和73.5%。The prepared total saponins were adsorbed on 3 times the amount of silica gel, volatilized to dryness, and used for later use; loaded into a column, 5 times the amount of total saponins on column chromatography silica gel was packed with chloroform wet method, and eluted with eluent repeatedly. , to make the silica gel fully sink and close; for sample loading and elution, slowly add the sample to the chromatography column, elute with chloroform-methanol (volume ratio 20:1) isocratic, and collect in sections. 4 times the column volume, merge the fractions containing notoginsenoside Fe and Fd after detection by thin layer chromatography, recover the solvent under reduced pressure to dryness, then use silica gel column chromatography, use ethyl acetate-methanol (volume ratio 3:1) ) isocratic elution, sectional collection, the collection amount of every stream is 3 times of column volumes, after TLC detection, merges respectively notoginsenoside Fe and Fd stream, and the solvent is recovered under reduced pressure to
实施例3Example 3
将15g三七叶粉碎成60目粉末,加90mL水在70℃下浸润0.5小时,然后加入150mL80%乙醇超声提取30分钟,收集提取液,过滤,滤渣回收,减压浓缩至相对密度为1.08;将浓缩液上DM-301型大孔吸附树脂柱,其中大孔吸附树脂与浓缩液的体积比为1:2,柱径与柱高比为1:12,先用水洗至流出液为无色,再用10倍柱体积的10%乙醇冲洗,弃去冲洗液,最后用体积分数为80%的乙醇全部洗脱,收集洗脱液,回收溶剂至干,即得富含稀有三七皂苷Fe和Fd的三七叶总皂苷3.10g,经香草醛-高氯酸UV法检查,总皂苷纯度为41.0%。经HPLC法检查,其中三七皂苷Fe含量4.24%,三七皂苷Fd含量8.24%。Pulverize 15g of Panax notoginseng leaves into 60 mesh powder, add 90mL of water to infiltrate at 70°C for 0.5 hours, then add 150mL of 80% ethanol for ultrasonic extraction for 30 minutes, collect the extract, filter, recover the filter residue, and concentrate under reduced pressure to a relative density of 1.08; Put the concentrated solution on a DM-301 macroporous adsorption resin column, wherein the volume ratio of the macroporous adsorption resin to the concentrated solution is 1:2, and the ratio of the column diameter to the column height is 1:12, first wash with water until the effluent is colorless , then rinsed with 10 times the column volume of 10% ethanol, discarded the rinse solution, and finally eluted with 80% ethanol by volume, collected the eluent, and recovered the solvent to dryness to obtain Fe rich in rare Panax notoginseng saponins. The total saponins of Panax notoginseng and Fd were 3.10 g, and the purity of total saponins was 41.0% by vanillin-perchloric acid UV method. The HPLC method showed that the Fe content of Panax notoginseng saponins was 4.24%, and the content of Panax notoginseng saponins Fd was 8.24%.
将制得的总皂苷吸附于5倍量的硅胶上,挥发至干,备用;装柱,将总皂苷15倍量的柱层析硅胶,用氯仿湿法装柱,反复用洗脱剂洗脱,使硅胶充分下沉紧密;上样及洗脱,将样品慢慢加入层析柱中,用氯仿-甲醇(体积比15:1)等度洗脱,分段收集,每流份收集量为4倍柱体积,经薄层色谱检测后合并含有三七皂苷Fe和Fd的流份,减压回收溶剂至干,再用硅胶柱层析法,用乙酸乙酯-甲醇(体积比10:1)等度洗脱,分段收集,每流份收集量为3倍柱体积,经薄层色谱检测后分别合并三七皂苷Fd和Fe流份,减压回收溶剂至干,得三七皂苷Fe18.3mg和Fd 20.1mg。HPLC检测纯度各为81.3%和70.6%。The obtained total saponins were adsorbed on 5 times the amount of silica gel, volatilized to dryness, and used for later use; the column was loaded, and 15 times the amount of total saponins was used for column chromatography on silica gel. , to make the silica gel fully sink and close; for sample loading and elution, slowly add the sample to the chromatography column, elute with chloroform-methanol (volume ratio 15:1) isocratic, and collect in sections. 4 times the column volume, the fractions containing Notoginsenoside Fe and Fd were combined after detection by thin layer chromatography, the solvent was recovered under reduced pressure to dryness, then silica gel column chromatography was used, and ethyl acetate-methanol (volume ratio 10:1) was used. ) isocratic elution, sectional collection, the collection amount of every fraction is 3 times of column volumes, after TLC detection, merge notoginsenoside Fd and Fe fractions respectively, and the solvent is recovered under reduced pressure to dryness to obtain notoginsenoside Fe18 .3mg and Fd 20.1mg. The purity detected by HPLC was 81.3% and 70.6%, respectively.
上述实施例仅列举了部分适用于本发明技术方案的条件,如温水的温度、浸泡时间等,实际上,在本发明所附权利要求保护的范围内,皆能够取得理想的效果,即相比现有技术大幅度提高三七总皂苷中Fe和Fd的含量,在此不一一细举。The above embodiment only enumerates some of the conditions applicable to the technical solution of the present invention, such as the temperature of warm water, soaking time, etc. In fact, within the scope of protection of the appended claims of the present invention, ideal effects can be achieved, that is, compared to The prior art greatly increases the content of Fe and Fd in the total saponins of Panax notoginseng, which will not be listed here.
以上所述的具体实施例,对本发明的目的、技术方案和有益效果进行了进一步详细说明,应理解的是,以上所述仅为本发明的具体实施例而已,并不用于限制本发明,凡在本发明的精神和原则之内,所做的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The specific embodiments described above further describe the purpose, technical solutions and beneficial effects of the present invention in detail. It should be understood that the above-mentioned specific embodiments are only specific embodiments of the present invention, and are not intended to limit the present invention. Within the spirit and principle of the present invention, any modifications, equivalent replacements, improvements, etc. made should be included within the protection scope of the present invention.
Claims (14)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610862430.3A CN106420871B (en) | 2016-09-28 | 2016-09-28 | Preparation method of total notoginsenoside rich in Fe and Fd and monomers Fe and Fd thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610862430.3A CN106420871B (en) | 2016-09-28 | 2016-09-28 | Preparation method of total notoginsenoside rich in Fe and Fd and monomers Fe and Fd thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106420871A CN106420871A (en) | 2017-02-22 |
| CN106420871B true CN106420871B (en) | 2020-06-19 |
Family
ID=58170957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610862430.3A Active CN106420871B (en) | 2016-09-28 | 2016-09-28 | Preparation method of total notoginsenoside rich in Fe and Fd and monomers Fe and Fd thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106420871B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102250906B1 (en) | 2018-08-06 | 2021-05-13 | 고려대학교 산학협력단 | Composition for Prevention and Treatment of Inflammatory Diseases Comprising Ginsenoside MC1 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111214523B (en) * | 2018-11-27 | 2024-10-29 | 澳门大学 | Extraction method for increasing the content of ginsenoside Rb3 in Panax notoginseng leaf and/or Panax notoginseng flower extract |
| CN115669673B (en) * | 2022-08-18 | 2024-06-21 | 澳门大学 | Application of notoginsenoside Fe and/or notoginsenoside Fd in preparing botanical fungicides and preventing and controlling agricultural fungal diseases |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1732964A (en) * | 2004-07-03 | 2006-02-15 | 山东绿叶天然药物研究开发有限公司 | Pharmaceutical composition, its preparation process and usage |
| CN1869050A (en) * | 2006-06-21 | 2006-11-29 | 海南亚洲制药有限公司 | Method of preparing notoginseng saponine Fe and diol group ginseng saponine from netoginseng leaf |
| CN101049331A (en) * | 2007-05-11 | 2007-10-10 | 浙江大学 | Preparation method for extracting purified general saponin from notoginseng of Chinese traditional medicine |
| CN101323635A (en) * | 2008-07-25 | 2008-12-17 | 中国科学院昆明植物研究所 | Notoginseng saponin ST-4, its pharmaceutical composition, its preparation method and its application |
| CN101884655A (en) * | 2009-05-13 | 2010-11-17 | 上海信谊百路达药业有限公司 | Method for preparing pseudo-ginseng flower extract |
| CN104435034A (en) * | 2014-11-28 | 2015-03-25 | 河北神威药业有限公司 | PNS (panax notoginseng saponins) and preparation method thereof |
| CN104817609A (en) * | 2015-04-01 | 2015-08-05 | 江苏省中医药研究院 | Notoginsenoside compound with liver cancer-resistant activity and its preparation method and use |
| CN105816471A (en) * | 2016-03-22 | 2016-08-03 | 哈尔滨珍宝制药有限公司 | Panax notoginseng saponin composition and preparation method and application thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1919239B (en) * | 2005-08-24 | 2010-09-29 | 天津天士力制药股份有限公司 | Traditional medicine composition for treating cardiovascular and cerebrovascular diseases |
-
2016
- 2016-09-28 CN CN201610862430.3A patent/CN106420871B/en active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1732964A (en) * | 2004-07-03 | 2006-02-15 | 山东绿叶天然药物研究开发有限公司 | Pharmaceutical composition, its preparation process and usage |
| CN1869050A (en) * | 2006-06-21 | 2006-11-29 | 海南亚洲制药有限公司 | Method of preparing notoginseng saponine Fe and diol group ginseng saponine from netoginseng leaf |
| CN101049331A (en) * | 2007-05-11 | 2007-10-10 | 浙江大学 | Preparation method for extracting purified general saponin from notoginseng of Chinese traditional medicine |
| CN101323635A (en) * | 2008-07-25 | 2008-12-17 | 中国科学院昆明植物研究所 | Notoginseng saponin ST-4, its pharmaceutical composition, its preparation method and its application |
| CN101884655A (en) * | 2009-05-13 | 2010-11-17 | 上海信谊百路达药业有限公司 | Method for preparing pseudo-ginseng flower extract |
| CN104435034A (en) * | 2014-11-28 | 2015-03-25 | 河北神威药业有限公司 | PNS (panax notoginseng saponins) and preparation method thereof |
| CN104817609A (en) * | 2015-04-01 | 2015-08-05 | 江苏省中医药研究院 | Notoginsenoside compound with liver cancer-resistant activity and its preparation method and use |
| CN105816471A (en) * | 2016-03-22 | 2016-08-03 | 哈尔滨珍宝制药有限公司 | Panax notoginseng saponin composition and preparation method and application thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102250906B1 (en) | 2018-08-06 | 2021-05-13 | 고려대학교 산학협력단 | Composition for Prevention and Treatment of Inflammatory Diseases Comprising Ginsenoside MC1 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106420871A (en) | 2017-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102492005B (en) | Method for preparing paeoniflorin and albiflorin | |
| CN106967137B (en) | Method for separating high-purity oleuropein by liquid chromatography through macroporous resin combined preparation | |
| CN104592341A (en) | Method for extracting asiaticoside and madecassoside from centella | |
| CN106420871B (en) | Preparation method of total notoginsenoside rich in Fe and Fd and monomers Fe and Fd thereof | |
| CN102423329A (en) | Method for decoloring panax notoginseng saponins extracting solution | |
| CN108042590A (en) | A kind of residual extract of Radix Ginseng stem and leaf of low agriculture and preparation method thereof | |
| CN102659864B (en) | Preparation method of anti-allergic natural product of 2-O-alpha-L-rhamnose-4,6,4'-trihydroxybenzophenone (THBP) | |
| WO2012019373A1 (en) | Method for preparing paeoniflorin and albiflorin | |
| CN102196814A (en) | Method for preparing extract fraction reinforced with ginsenosides Rg1 or Rb1 from ginseng | |
| CN103408610B (en) | The method of arbutin is extracted from leaf of pear tree | |
| CN107126452A (en) | Gypenosides and preparation method thereof | |
| CN102924537B (en) | Method for preparing hyperoside and isoquercitrin simultaneously from dogbane leaves | |
| CN102234298A (en) | Method for extracting and purifying amygdalin from peach seeds | |
| CN101513438A (en) | Method for extracting panax notoginseng saponins from fresh panax notoginsengs | |
| CN102617696B (en) | Preparation method of asiaticoside | |
| CN101492510A (en) | Method for purifying liquorice polyose | |
| CN102250183B (en) | Method for preparing high-purity ginsenoside Re by using ginseng flower buds as raw materials | |
| CN105294793B (en) | The separation method of aurantiin in aizoon stonecrop | |
| CN103613629A (en) | Method for preparing high-purity mogroside IIE from momordica grosvenori | |
| CN116251134B (en) | A kind of Momordica grosvenori root hypoglycemic composition, application and preparation method | |
| CN106589045A (en) | Method for preparing aescin of Chinese buckeye seeds | |
| CN108440619B (en) | Method for preparing strychnine glycosides from Cornus officinalis extract | |
| CN102070569A (en) | Method for enriching and purifying 3,4-divanillyltetrahydrofuran in nettle | |
| CN107375537B (en) | Preparation method of tea polyphenols in Southwest camellia | |
| CN108743665A (en) | The preparation method of sesquiterpenoids ingredient in a kind of root of three-nerved spicebush |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |